Coronary disease & ACSCohort study
Prognostic Impact of Renal Function on Outcomes After Physiology-Guided Coronary Revascularization: Insights From the J-PRIDE Registry
- subanalysis of the J-PRIDE registry, a prospective multicenter study
- 20 Japanese centers
Authors' conclusion
Patients with ESRD exhibited distinct physiological characteristics and substantially worse outcomes, highlighting the need for tailored coronary revascularization strategies in this population.
Study context
- Population
- Patients who underwent both fractional flow reserve (FFR) and NHPR assessment, categorized by estimated glomerular filtration rate, Japan, September 2019 to February 2021patients, 4296 lesions · non-CKD 1,639 · chronic kidney disease (CKD) 1,321 · end-stage renal disease (ESRD) 234
- Participants
- 3,194 patients
- Exposure
- ESRD group vs CKD and non-CKD groups
- non-CKDn = 1,639reference
- CKDn = 1,321reference
- ESRDn = 234
- Outcome
- Target vessel failure:
- Composite of cardiac death
- Target vessel myocardial infarction
- Clinically driven target vessel revascularization
- Follow-up
- 1 year
Main finding
As reported in the abstract
Adjusted hazard ratio (95% CI)P value
ESRD vs CKD
3.09(1.60–5.96)
P < 0.001ESRD vs non-CKD
2.88(1.98–5.47)
P = 0.001Observational data: associations, not effects.
Further findings
FFR-/NHPR+ discordance
| Outcome | non-CKD | CKD | ESRD |
|---|---|---|---|
| NHPR cutoff predicting FFR ≤0.80 | 0.89 | 0.89 | 0.85 |
- FFR-/NHPR+ discordance: P <0.001
Overall prevalence of FFR/NHPR discordance
- Comparable across groups (23.6%, 19.7%, and 19.7%)
- P = 0.24
Risk of FFR-/NHPR+ lesions in the ESRD group
- FFR-/NHPR+ lesions in the ESRD group exhibited an excess risk compared with other lesions
Revascularization of FFR+/NHPR- lesions
- Revascularization was beneficial in non-CKD patients with FFR+/NHPR- lesions, whereas no clear benefit was observed in patients with CKD and ESRD
Original publication
Prognostic Impact of Renal Function on Outcomes After Physiology-Guided Coronary Revascularization: Insights From the J-PRIDE Registry. Circ Cardiovasc Interv. Published 27 April 2026. doi:10.1161/circinterventions.125.016454
Summarised from the published abstract; every number is checked against it